Clinical Trials Browser

Uterine Cervical Neoplasms, Kwashiorkor, Lung Neoplasms, Neoplasms, Malnutrition

Uterine Cervical Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Gynecologic Cancer

Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

Platinum-sensitive Relapsed Ovarian Cancer

Endometrial Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms, Neurotoxicity Syndromes

Ovarian Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Cervical Intraepithelial Neoplasia Grade 2/3

Gestational Trophoblastic Disease

Gestational Trophoblastic Disease

Hydatidiform Mole, Gestational Trophoblastic Disease

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Ovarian Neoplasms

Recurrent Platinum-resistant Ovarian Cancer

Endometrial Clear Cell Adenocarcinoma

Brenner Tumor, Fallopian Tube Neoplasms

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Ovarian Neoplasms

Ovarian Neoplasms

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Peritoneal Neoplasms, Colorectal Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Gestational Trophoblastic Disease

Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Carcinoma, Ovarian Epithelial

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Chemotherapy-Induced Febrile Neutropenia

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms, Pelvic Floor Disorders

Clinical Trials

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

SENGA

MITO-8

AL3818

PROPER

PORTEC-3

SELENIUM

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer

MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer

MITO-7

MITO16MANGO2b

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

ICON9

A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer

APRICITY

Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

ReCure

Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer

A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills

A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

NItCHE-MITO33

Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

DNA Methylation Testing for the Screening of Uterine Cervical Lesion

FERMATA

A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

HIPECOV

GTN-01

ROCOCO

EHTASEOCCS

HIPOVA-01

Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer

Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer

NACTcervix

STARS

TACO

Different Surgical Approaches in Patients of Early-stage Cervical Cancer